Commercialization of medical artificial intelligence technologies: challenges and opportunities
Bibliographic record
Abstract
Artificial intelligence (AI) technologies are already having significant impacts in healthcare 1 . For example, AI-guided imaging has shown promise in the management of vascular diseases, including carotid, aortic, and peripheral artery disease, which collectively affect over 200 million individuals globally and lead to significant mortality/morbidity related to catastrophic complications such as aneurysm rupture, stroke, and limb loss 2 , 3 , 4 . These diseases are typically managed by vascular specialists who rely on imaging modalities including ultrasound, computed tomography (CT), and fluoroscopy for diagnosis/treatment 5 . Recent advancements, such as three-dimensional reconstruction software and fluoroscopic roadmaps, have transformed pre-operative planning and intra-operative guidance 5 . However, despite the growing availability of AI tools, their integration into routine diagnostic vascular imaging remains limited. This is largely due to persistent financial, regulatory, and implementation challenges that impede clinical translation. Many AI solutions are developed without adequate alignment to regulatory pathways or quality assurance frameworks, which hinders their adoption in practice 6 . This is particularly concerning given that vascular diseases are frequently underdiagnosed 7 . For example, abdominal aortic aneurysms (AAA) are often captured incidentally on medical images obtained during the investigation of other abdominal concerns, including assessment of liver, gallbladder, and kidney conditions, rather than actively screened for despite guideline recommendations 8 . Consequently, many AAA’s remain undetected until rupture, which carry mortality rates up to 80% 9 . AI-enhanced imaging holds potential to increase screening uptake and facilitate timely, elective intervention prior to rupture 10 . In this article, we examine a recently developed deep learning algorithm for AAA screening and explore the broader challenges and opportunities associated with commercializing AI technologies to deliver tangible clinical impact.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.000 | 0.002 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.001 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".